At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Psychophysiology of Delayed Extinction and Reconsolidation in Humans
In Brief
A Phase 4 clinical trial evaluating Propranolol, Reactivation, and 2 other interventions for Posttraumatic Stress Disorder and Anxiety Disorder. Completed, enrolled 186 participants across 1 site.
Detailed Summary
The aim of this project is to create fear conditioning paradigm within which the relative strengths of various novel pharmacological and behavioral interventions can be tested. These interventions are intended to reduce the fearfulness associated with fear conditioning by blocking a memory process known as reconsolidation. In fear conditioning, a "conditioned" stimulus (CS) is paired with an aversive "unconditioned" stimulus (US) such as an electric shock, until presentation of the CS alone comes to elicit a fear conditioned response (CR). The investigators hypothesize that by using a more highly prepared CS (i.e. video of spiders); more sensitive subjects (individuals with stronger acquired CRs); and additional experimental probes for the presence of the latent CR, the investigators may develop a normal human paradigm that is not plagued by previously observed floor effects (i.e. intervention is 100% effective), within which both the established techniques of propranolol and delayed extinction will produce significant, but only partial, CR reduction. This would leave room to test and compare potentially more powerful candidate reconsolidation-blocking or memory-updating interventions. To achieve these aims, subjects will undergo a four-day fear conditioning and delayed extinction protocol. Skin conductance response data will be gathered across the different phases of the experiment.
Study Details
Timeline
Interventions
40mg single pill
subject is re-exposed to CS+R on day 2 (code for CS that is both paired with shock and reactivated on day 2)
1800mg, 9 tablets
32 IU, 8 self-administered intranasal sprays, 4 in each nostril